These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8703799)

  • 41. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
    Akabutu JJ; Chan JR
    Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
    [No Abstract]   [Full Text] [Related]  

  • 42. Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.
    Bian Z; Xu LP; Fu Q; Huo M; Liu L; Zhao X; Huang XJ; Liu J
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):252-259. PubMed ID: 29061533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation.
    Negrin RS; Kusnierz-Glaz C; Blume KG; Strober S
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S31-3. PubMed ID: 8722331
    [No Abstract]   [Full Text] [Related]  

  • 44. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Contribution of hematopoietic growth factors and especially in the context of grafts of hematopoietic stem cells].
    Fouillard L
    Ann Pharm Fr; 1996; 54(4):157-61. PubMed ID: 8881102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T
    Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential of patients' peripheral blood mononuclear cells to differentiate into dendritic cells after hematopoietic stem cell transplantation.
    Yoshino H; Watanabe N; Takahashi K; Ogura K; Akagi T; Kubo K; Kashiwakura I
    Life Sci; 2011 Dec; 89(25-26):946-55. PubMed ID: 22036621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
    Martino M; Recchia AG; Moscato T; Fedele R; Neri S; Gentile M; Alati C; Vincelli ID; Piro E; Penna G; Musolino C; Ronco F; Molica S; Morabito F
    Cytotherapy; 2015 Oct; 17(10):1485-93. PubMed ID: 26188967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transplantation of allogeneic peripheral blood stem cells.
    Bensinger WI; Buckner CD; Demirer T; Storb R; Appelbaum FA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S56-7. PubMed ID: 8722338
    [No Abstract]   [Full Text] [Related]  

  • 51. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
    Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
    J Clin Oncol; 1995 Oct; 13(10):2547-55. PubMed ID: 7595706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation.
    Matsunaga T; Sakamaki S; Kohgo Y; Ohi S; Hirayama Y; Niitsu Y
    Bone Marrow Transplant; 1993 Feb; 11(2):103-8. PubMed ID: 7679596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor.
    Suzue T; Kawano Y; Takaue Y; Kuroda Y
    Exp Hematol; 1994 Aug; 22(9):888-92. PubMed ID: 7520392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.
    Jyung RW; Wu L; Pierce GF; Mustoe TA
    Surgery; 1994 Mar; 115(3):325-34. PubMed ID: 7510423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on neutrophil formation and function.
    Khwaja A; Linch DC
    Curr Opin Hematol; 1994 May; 1(3):216-20. PubMed ID: 9371285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulocyte colony-stimulating factor affects serum levels of soluble interleukin-2 receptors after allogeneic stem cell transplantation.
    Remberger M; Sundberg B
    Haematologica; 2005 Mar; 90(3):427-9. PubMed ID: 15749688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal regimens for the mobilization and collection of peripheral blood progenitor cells from normal donors.
    Roberts AW; Grigg AP
    Leuk Lymphoma; 1997 Sep; 27(1-2):77-82. PubMed ID: 9373198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose therapy and growth factor mobilized peripheral blood progenitor cell support for responding patients with metastatic breast cancer.
    Stadtmauer EA; Hodi FS; Sickles C; Biggs DD; Mangan P; Buzby G; Zaleta E; Silberstein L
    Prog Clin Biol Res; 1994; 389():487-95. PubMed ID: 7535458
    [No Abstract]   [Full Text] [Related]  

  • 60. Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.
    Dreger P; Steinmann J; Drost R; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
    Prog Clin Biol Res; 1994; 389():407-13. PubMed ID: 7535449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.